ArticleBioinformatics (Oxford, England)2026
DECANT: decoupling mechanism from context in single-cell drug perturbation representation.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
motivationSingle-cell chemical perturbation profiling offers a powerful opportunity to organize drugs by shared mechanism-associated transcriptional responses, but observed transcriptional responses are entangled with contextual variation from cell identity, dose, and treatment time. As a result, models that perform well in perturbation-response prediction may still learn latent spaces dominated by context-associated structure rather than transferable drug-associated signal. We developed DECANT to learn mechanism-aligned perturbation representations that remain stable across context shifts while preserving response fidelity.
resultsDECANT represents each perturbation as a matched treated-control cell set and separates a context-suppressed, mechanism-aligned perturbation representation from context-dependent response information. The resulting mechanism-aligned perturbation space is shaped to support drug-level retrieval and biological interpretation. Under a fixed drug-level unseen-compound benchmark, DECANT achieved the strongest overall response-difference profile among adapted published perturbation models and strong pseudo-bulk baselines across gene- and program-level metrics. Beyond prediction, DECANT produced embeddings that remained stable across changes in dose, cell line, and treatment time, recovered drug neighborhoods enriched for shared mechanism-family annotations, and linked these neighborhoods to interpretable downstream consequence programs. Ablation analyses showed that mechanism-context decoupling provided the main signal-separation backbone, whereas retrieval-oriented shaping was critical for organizing local representation-space geometry. These results support DECANT as a framework for learning context-robust, mechanism-aligned perturbation representations from single-cell transcriptional responses, providing a basis for mechanism-aligned perturbation analysis and representation-based compound prioritization. AVAILABILITY AND IMPLEMENTATION: The DECANT web server is publicly available at http://bliulab.net/DECANT. All source code and analysis scripts are available at https://github.com/bliulab/DECANT and archived on Zenodo at https://doi.org/10.5281/zenodo.21216567.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.